The company sees big money in leveling up its tech for screening Americans' blood, and tariffs could mean further U.S.

Abbott Laboratories announced a plan to invest $500 million to expand its U.S. manufacturing footprint. The medical device maker will upgrade facilities in both Illinois and Texas to expand its ...

Abbott Labs boosted its earnings in the first quarter and hinted that its full-year guidance might have gotten a lift were it ...

The company plans to expand its manufacturing and R&D operations in its diagnostics transfusion business in Lake County, Illinois. Abbott Laboratories said Wednesday it will make a big investment ...

Abbott Laboratories plans to hire as many as 200 ... in Lake County are related to Abbott’s transfusion diagnostics business, which is responsible for screening the U.S. blood supply, Ford ...

The Illinois expansion will happen at the company’s headquarters campus in Abbott Park. It's also growing in Dallas.

Abbott Laboratories has developed a new blood screening ... $500M investment among the sites isn't yet known, but the Dallas Business Journal reported Abbott plans to add 100 jobs at its Irving ...

Abbott Laboratories (NYSE:ABT) is set to report its first-quarter earnings results on Wednesday, April 16th, before the ...

Abbott Labs ABT1.27%increase ... given the momentum they were seeing in the healthcare-products maker’s base business.